N,N-bis(2-chloroethyl)cyclohexylamine hydrochloride | 879-61-8

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: N,N-bis(2-chloroethyl)cyclohexylamine hydrochloride
• 英文别名: bis-(2-chloro-ethyl)-cyclohexyl-amine; hydrochloride；Bis-(2-chlor-aethyl)-cyclohexyl-amin; Hydrochlorid；N,N-bis-(beta-chloroethyl)-cyclohexylamine hydrochloride；N-cyclohexyl-2,2'-dichlorodiethylamine hydrochloride；Cyclohexylamine, N,N-bis(2-chloroethyl)-, hydrochloride；N,N-bis(2-chloroethyl)cyclohexanamine;hydrochloride
• CAS: 879-61-8
• 化学式: C₁₀H₁₉Cl₂N*ClH
• 分子量: 260.635
• InChiKey: NQPAICOXPNRJSR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.52
• 重原子数：
  14
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  3.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  N,N-bis(2-chloroethyl)cyclohexylamine hydrochloride 生成 N-Cyclohexyl-bis-<2-(4-brom-butoxy)-aethyl>-amin
  参考文献：
  名称：

  Sieber,G.; Ulbricht,I., Journal fur praktische Chemie (Leipzig 1954), 1965, vol. 29, p. 43 - 50

  摘要：

  DOI：

文献信息

• 1-Substituted-4-(1,2-diphenylethyl)piperazine derivatives and
  申请人：Dainippon Pharmaceutical Co., Ltd.

  公开号：US04080453A1

  公开（公告）日：1978-03-21

  1-Substituted-4-(1,2-diphenylethyl)piperazine derivatives of the formula: ##STR1## wherein X is 2- or 3-hydroxy, 2-methoxy, 3-methyl, 3-alkoxy having 1 to 4 carbon atoms, or 2- or 3-alkanoyloxy having 2 to 5 carbon atoms; R is allyl, 3-hydroxyisoamyl, 3-methyl-2-butenyl, 3-methyl-3-butenyl, propyl, an unsubstituted monocycloalkyl having 5 to 8 carbon atoms, 2-chlorophenyl, or a phenyl substituted by hydroxy or methoxy; with proviso that when X is a substituent at position 2, R is cyclohexyl and when X is 3-methyl, R is 2-methoxyphenyl or an unsubstituted monocycloalkyl having 6 to 8 carbon atoms, and their pharmaceutically acceptable salts, and the preparation thereof, and analgesic or antitussive compositions containing the same as the essentially active ingredient.

  1-取代-4-(1,2-二苯乙基)哌嗪衍生物的化学式为：##STR1## 其中X为2-或3-羟基，2-甲氧基，3-甲基，3-烷氧基（碳原子数为1至4），或2-或3-烷酰氧基（碳原子数为2至5）；R为烯丙基，3-羟基异戊基，3-甲基-2-丁烯基，3-甲基-3-丁烯基，丙基，未取代的含有5至8个碳原子的单环烷基，2-氯苯基，或被羟基或甲氧基取代的苯基；但当X为2位置的取代基时，R为环己基，当X为3-甲基时，R为2-甲氧基苯基或未取代的含有6至8个碳原子的单环烷基，以及其药学上可接受的盐，其制备方法，以及含有其作为基本活性成分的镇痛或止咳组合物。
• 1-(4-alkylthiophenyl)-2-(substituted or unsubstituted
  申请人：Zambon S.p.A.

  公开号：US04638003A1

  公开（公告）日：1987-01-20

  N-substituted derivatives of 1-(4'-alkylthiophenyl)-2-amino-1,3-propanediol, their salts with pharmaceutically acceptable organic and inorganic acids, processes for preparing them, pharmaceutical compositions containing them and intermediates useful in the preparation thereof. The novel derivatives according to this invention are endowed with calcium antagonist activity and are useful as antiarrhythmic and vasodilating agents.

  1-(4'-烷基硫代苯基)-2-氨基-1,3-丙二醇的N-取代衍生物，其与药用可接受的有机和无机酸盐，用于制备它们的方法，含有它们的药物组合物以及用于制备它们的中间体。根据本发明的新颖衍生物具有钙拮抗活性，可用作抗心律失常和扩血管剂。
• 1-Substituted-4-(1,2-diphenylethyl)piperazine derivatives and their
  申请人：Dainippon Pharmaceutical Co., Ltd.

  公开号：US03957788A1

  公开（公告）日：1976-05-18

  1-Substituted-4-(1,2-diphenylethyl)piperazine derivatives of the formula: ##SPC1## Wherein X is hydroxy, methoxy, methyl or trifluoromethyl; and R is an unsubstituted monocycloalkyl group having 6 to 8 carbon atoms or 2-methoxyphenyl; provided that when X is hydroxy, R is cyclohexyl, and when X is trifluoromethyl, R is 2-methoxyphenyl, And their pharmaceutically acceptable salts, which have excellent analgesic, anti-tussive and anti-inflammatory activities, without undesirable side effect such as narcotic activity, and a process for the preparation thereof.

  1-取代的4-(1,2-二苯乙基)哌嗪衍生物的化学式如下：##SPC1## 其中X为羟基、甲氧基、甲基或三氟甲基；R为未取代的含有6至8个碳原子的单环烷基基团或2-甲氧基苯基；但当X为羟基时，R为环己基，当X为三氟甲基时，R为2-甲氧基苯基。其药用盐具有出色的镇痛、镇咳和抗炎活性，且无毒性活性等不良副作用，以及其制备方法。
• Synthesis and structure-activity relationships of 1-substituted 4-(1,2-diphenylethyl)piperazine derivatives having narcotic agonist and antagonist activity
  作者：Kagayaki Natsuka、Hideo Nakamura、Yoshinori Nishikawa、Toshiyuki Negoro、Hitoshi Uno、Haruki Nishimura

  DOI：10.1021/jm00393a017

  日期：1987.10

  Racemates and enantiomers of 1-substituted 4-[2-(3-hydroxyphenyl)-1-phenylethyl]piperazine derivatives (3-18) were synthesized, and their analgesic and other pharmacological activities and structure-activity relationships were investigated. The S-(+) enantiomers of 2a, 5, 7, 9, 10, and 15-18 had a stronger analgesic activity than their R-(-) enantiomers; analgesic activity of the strongest one [(S)-(+)-10]

  合成了1-取代的4- [2-（3-（羟基苯基）-1-苯基乙基]哌嗪衍生物（3-18）的外消旋体和对映体，并研究了它们的止痛及其他药理活性和构效关系。2a，5、7、9、10和15-18的S-（+）对映体比其R-（-）对映体具有更强的镇痛活性。最强的一种[（S）-（+）-10]的镇痛活性是吗啡的105倍。这些化合物的S-（+）对映异构体相对于其（C-9）不对称中心具有与吗啡相反的构型，但与Met5-脑啡肽的酪氨酸残基的构型相同。16和18的R-（-）对映体显示出麻醉拮抗剂活性，而S-（+）对映体则没有。（R）-（-）-18具有与喷他佐辛相当的镇痛和麻醉剂拮抗活性，但没有明显的身体依赖性。从这些结果表明，与吗啡及其替代物相比，这些化合物表现出不常见的对映选择性，并且属于具有有效止痛活性的新化合物系列。
• beta, beta'-bis(substituted sulfonylthio) compounds
  申请人：DOW CHEMICAL CO

  公开号：US03338945A1

  公开（公告）日：1967-08-29